Rhinomed (ASX:RNO) and 138267 (COM.TO) (TSE:COM) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, institutional ownership and profitability.
Earnings and Valuation
This table compares Rhinomed and 138267 (COM.TO)'s gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Rhinomed | $4.58 million | 0.00 | C$-8,883,314.72 | A($0.04) | N/A |
138267 (COM.TO) | N/A | N/A | N/A | N/A | N/A |
138267 (COM.TO) has lower revenue, but higher earnings than Rhinomed.
Profitability
This table compares Rhinomed and 138267 (COM.TO)'s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Rhinomed | N/A | N/A | N/A |
138267 (COM.TO) | N/A | N/A | N/A |
Analyst Recommendations
This is a summary of recent ratings and recommmendations for Rhinomed and 138267 (COM.TO), as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Rhinomed | 0 | 0 | 0 | 0 | N/A |
138267 (COM.TO) | 0 | 0 | 0 | 0 | N/A |
Summary
Rhinomed beats 138267 (COM.TO) on 1 of the 1 factors compared between the two stocks.